WO2013015586A3 - Composition de vaccin destinée à prévenir et à traiter la colibacillose et la salmonellose chez la volaille, contenant une souche de salmonelle exprimant des facteurs de virulence pathogènes d'escherichia coli de volaille - Google Patents

Composition de vaccin destinée à prévenir et à traiter la colibacillose et la salmonellose chez la volaille, contenant une souche de salmonelle exprimant des facteurs de virulence pathogènes d'escherichia coli de volaille Download PDF

Info

Publication number
WO2013015586A3
WO2013015586A3 PCT/KR2012/005860 KR2012005860W WO2013015586A3 WO 2013015586 A3 WO2013015586 A3 WO 2013015586A3 KR 2012005860 W KR2012005860 W KR 2012005860W WO 2013015586 A3 WO2013015586 A3 WO 2013015586A3
Authority
WO
WIPO (PCT)
Prior art keywords
poultry
salmonellosis
preventing
escherichia coli
vaccine composition
Prior art date
Application number
PCT/KR2012/005860
Other languages
English (en)
Korean (ko)
Other versions
WO2013015586A9 (fr
WO2013015586A2 (fr
Inventor
이존화
아군 아툴차우다리
기꾸미쓰다
오인경
Original Assignee
전북대학교산학협력단
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 전북대학교산학협력단 filed Critical 전북대학교산학협력단
Publication of WO2013015586A2 publication Critical patent/WO2013015586A2/fr
Publication of WO2013015586A9 publication Critical patent/WO2013015586A9/fr
Publication of WO2013015586A3 publication Critical patent/WO2013015586A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0258—Escherichia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0275—Salmonella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

La présente invention concerne un vaccin pour volaille, contenant une souche de Salmonelle atténuée contenant des facteurs de virulence appartenant à la bactérie pathogène Escherichia coli de volaille, ainsi qu'une composition de vaccin utilisant celui-ci destinée à prévenir et à traiter la colibacillose et la salmonellose chez la volaille. La présente invention concerne en outre un procédé destiné à augmenter les réactions immunitaires chez la volaille en inoculant ledit vaccin à la volaille de sorte à induire des réactions immunitaires chez la volaille et à prévenir la colibacillose et la salmonellose de manière sûre et efficace.
PCT/KR2012/005860 2011-07-22 2012-07-23 Composition de vaccin destinée à prévenir et à traiter la colibacillose et la salmonellose chez la volaille, contenant une souche de salmonelle exprimant des facteurs de virulence pathogènes d'escherichia coli de volaille WO2013015586A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020110073226A KR101374649B1 (ko) 2011-07-22 2011-07-22 가금류의 병원성 대장균의 병원성 인자를 발현하는 살모넬라균을 포함하는 가금류의 병원성 대장균증 및 살모넬라균증의 예방 및 치료용 백신 조성물.
KR10-2011-0073226 2011-07-22

Publications (3)

Publication Number Publication Date
WO2013015586A2 WO2013015586A2 (fr) 2013-01-31
WO2013015586A9 WO2013015586A9 (fr) 2013-04-04
WO2013015586A3 true WO2013015586A3 (fr) 2013-05-23

Family

ID=47601634

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2012/005860 WO2013015586A2 (fr) 2011-07-22 2012-07-23 Composition de vaccin destinée à prévenir et à traiter la colibacillose et la salmonellose chez la volaille, contenant une souche de salmonelle exprimant des facteurs de virulence pathogènes d'escherichia coli de volaille

Country Status (2)

Country Link
KR (1) KR101374649B1 (fr)
WO (1) WO2013015586A2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101518872B1 (ko) * 2013-05-14 2015-05-22 대한민국(관리부서 : 농림축산식품부 농림축산검역본부) 가금의 세균성 전신성 질병 원인균 진단용 프라이머 세트 및 상기 프라이머 세트를 포함하는 진단 키트
KR101856736B1 (ko) * 2016-02-29 2018-05-11 (주)비손바이오로직스 가금티푸스 및 살모넬라증 예방을 위한 내독소가 감소된 살모넬라 3가 불활화 백신 조성물
KR20190070457A (ko) 2017-12-13 2019-06-21 주식회사 오투파워 이산화염소를 포함하는 닭 대장균증 예방을 위한 음용수 첨가용 조성물
CN108992669B (zh) * 2018-08-27 2022-03-22 广州汇高生物科技有限公司 防治呼吸道感染的复合卵黄抗体组合物、雾化吸入溶液剂及制备工艺与应用

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20080105099A (ko) * 2008-09-22 2008-12-03 브리제 유니버시타이트 브루셀 약독화 살모넬라 생백신

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101151004B1 (ko) * 2009-08-31 2012-06-22 전라북도 소의 병원성 대장균의 부착인자가 형질전환된 약독화 살모넬라균 변이주 및 이를 포함하는 소의 대장균증 및 살모넬라균증의 예방 및 치료용 백신조성물

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20080105099A (ko) * 2008-09-22 2008-12-03 브리제 유니버시타이트 브루셀 약독화 살모넬라 생백신

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
CHAUDHARI ATUL A.: "Efficacy of a live recombinant vaccine constructed with attenuated salmonella delivery system expressing antigens for avian pathogenic Escherichia coli in chickens", CHONBUK NATIONAL UNIVERSITY PHD THESIS, 2010 *
OH, IN GYEONG: "Evaluation of systemic and mucosal immune responses in mice administered with novel recombinant Salmonella vaccines for avian pathogenic E.coli", GRADUATED SCHOOL OF CHONBUK NATIONAL UNIVERSITY, 2007 *

Also Published As

Publication number Publication date
WO2013015586A9 (fr) 2013-04-04
KR101374649B1 (ko) 2014-03-17
KR20130011809A (ko) 2013-01-30
WO2013015586A2 (fr) 2013-01-31

Similar Documents

Publication Publication Date Title
PH12017501146A1 (en) Chemical mitigants in animal feed and feed ingredients
MX2016009898A (es) Tratamientos para acne resistente.
MY169328A (en) Compositions for the treatment of dry eye
PH12016500511A1 (en) Selective grp94 inhibitors and uses thereof
MX2017001379A (es) Producto antiseptico, proceso para prepararlo y su uso.
WO2012145651A3 (fr) Composés destinés au traitement de troubles neuropsychiatriques
WO2012064806A3 (fr) Procédés et compositions pour l'activation de gènes imprimés silencieux
NZ703597A (en) Mutant fragments of ospa and methods and uses relating thereto
WO2012097185A3 (fr) Vaccin omv contre les infections par burkholderia
PH12016502002A1 (en) Novel bacteriophage and composition comprising same
BR112017009330A2 (pt) planta transgênica que compreende um polinucleotídeo que codifica um domínio variável de anticorpo de cadeia pesada
WO2013015586A3 (fr) Composition de vaccin destinée à prévenir et à traiter la colibacillose et la salmonellose chez la volaille, contenant une souche de salmonelle exprimant des facteurs de virulence pathogènes d'escherichia coli de volaille
MX371095B (es) Inhibidores de metionina aminopeptidasa-2 y metodos de tratamiento de la obesidad.
MX2021002851A (es) Reutilizacion de agente cloroso activado para el tratamiento de carne y aves.
BR112016008895A8 (pt) métodos para formação de compostos homoalílicos pela reação de precursores de ciclopropilvinila com ácido de bronsted, e para formação de ambrox
MX2015001051A (es) Derivados de manosa, un proceso para su preparacion y sus usos como un farmaco.
CL2012002902A1 (es) Cepas de bacteriofagos especifica contra bacterias pertenecientes al genero vibrio para la profilaxis y terapia de vibrio anguillarum; y composicion antibacteriana que comprende dicha cepas.
WO2013067531A3 (fr) Méthodes d'utilisation de micro-arn 195 pour la neuroprotection
TR201910413T4 (tr) Benralizumab kullanarak astım semptomlarının iyileştirilmesine yönelik yöntemler.
WO2015013709A3 (fr) Méthode de traitement de l'épaississement de la peau
WO2013108041A3 (fr) Matières améliorées
MX2014009957A (es) Composiciones y métodos para disminuir los conteos de microorganismos patógenos en productos alimenticios.
MX2019011026A (es) Nueva vacuna de adn dirigida a pd-l1 para inmunoterapia de cancer.
MX2018014532A (es) Un metodo para reducir la contaminacion de los huevos.
UA114511C2 (uk) Стійкий до ампіциліну текстуруючий штам молочнокислих бактерій

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 12817183

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 12817183

Country of ref document: EP

Kind code of ref document: A2